Dr Christine Labeur
With a background in biochemistry, Christine has extensive CMC experience, working for and with various biotech and CDMO’s for both small and large molecules in management positions.
This includes 7 years as an Associate Director at Ablynx developing single chain recombinant antibodies for therapeutic use, where she built and managed the state of the art analytics teams (R&D and GMP QC Lab) that delivered several molecules ready for the clinic and market.
Dr Jennifer Sims
More than 25 years’ experience in the specialist biotech and global Pharma, and UK/European regulatory agencies. Prior to becoming an independent consultant in 2012, Jenny was Head of Translational Sciences & Safety for Novartis Biologics. She specializes in integrated non-clinical development, including safety assessment, translational PK-PD, immunogenicity risk assessments and regulatory strategies for biopharmaceuticals and advanced therapeutic products.